A randomized, double-blind, placebo-controlled study of risperidone monotherapy in ambulatory bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder.

Trial Profile

A randomized, double-blind, placebo-controlled study of risperidone monotherapy in ambulatory bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2011

At a glance

  • Drugs Risperidone (Primary)
  • Indications Bipolar disorders; Generalised anxiety disorder; Panic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jun 2011 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 21 Jun 2011 Actual initiation date (Feb 2004) added as reported by ClinicalTrials.gov.
    • 01 Jun 2009 Results published in the Journal of Affective Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top